GO:0060309 elastin catabolic process: Degradation Pathway, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0060309 elastin catabolic process describes the biochemical breakdown of elastin, the crosslinked glycoprotein that forms elastic fibers in connective tissue.
• Elastin catabolism is carried out by elastases, including serine proteases such as neutrophil elastase and matrix metalloproteinases (MMPs), and is tightly balanced by inhibitors in healthy tissue.
• Dysregulated elastin degradation contributes to pulmonary fibroelastosis, emphysema, vascular remodeling, and skin aging.
• Experimental study of elastin catabolism uses proteolysis assays, quartz crystal microbalance and nanoplasmonic sensing, atomic force microscopy, and extracellular matrix imaging.
• CRISPR knockout, point-mutation, knock-in, and overexpression models allow causal testing of elastase and MMP genes in elastin degradation.
• Targeting elastin catabolic process is a therapeutic strategy in fibrotic, inflammatory, and age-related diseases.
Description
Elastin is a highly hydrophobic, randomly coiled, crosslinked glycoprotein that forms elastic fibers in connective tissue, providing reversible extensibility to skin, lungs, and arteries. The controlled breakdown of elastin, defined as the elastin catabolic process (GO:0060309), is essential for tissue remodeling and homeostasis, but its dysregulation is a hallmark of several chronic diseases. Understanding this process at the molecular level requires knowledge of the proteases that cleave elastin, the inhibitors that restrain them, and the cellular contexts in which degradation occurs. Recent reviews highlight that elastin catabolism is not merely a degradative endpoint but an actively regulated process that releases bioactive peptides and alters extracellular matrix (ECM) mechanics. In this article, we integrate the QuickGO definition with verified PubMed literature to provide a research-grade overview of GO:0060309, its key genes, disease relevance, and experimental methods, including CRISPR-based models for functional validation.
elastin catabolic process At A Glance
| GO ID | GO:0060309 |
|---|---|
| GO term | elastin catabolic process |
| Ontology | biological_process |
| Synonym | elastin breakdown; elastin catabolism; elastin degradation |
| Major function | Proteolytic breakdown of elastin in the extracellular matrix |
| Definition source | QuickGO |
| Related cellular component | Extracellular matrix, elastic fiber |
| Key enzymes | Elastases (e.g., neutrophil elastase, MMPs) |
| Disease relevance | Pulmonary fibroelastosis, emphysema, vascular disease, skin aging |
What Is GO:0060309?
According to the Gene Ontology, GO:0060309 elastin catabolic process is defined as the chemical reactions and pathways resulting in the breakdown of elastin, a glycoprotein that is randomly coiled and crosslinked to form elastic fibers found in connective tissue. This process encompasses proteolytic cleavage of elastin by elastases and other proteases, leading to the disassembly of elastic fibers and the release of soluble elastin-derived peptides. It is a biological process that occurs in the extracellular matrix and is distinct from elastin biosynthesis or assembly.
Why Is elastin catabolic process Important in Cell Biology?
Elastin catabolic process is critical because elastin is an exceptionally long-lived protein, and its degradation is irreversible in most adult tissues. Excessive or insufficient elastin breakdown disrupts tissue mechanics and signaling, contributing to diseases such as pulmonary fibroelastosis, chronic obstructive pulmonary disease, aortic aneurysms, and skin aging. Studying GO:0060309 helps researchers identify therapeutic targets and biomarkers for these conditions.
• Elastin catabolism maintains ECM homeostasis and enables tissue remodeling during development and repair.
• Dysregulated elastin degradation is a feature of pulmonary fibroelastosis and interstitial lung diseases.
• Elastin-derived peptides can act as signaling molecules that influence cell behavior and inflammation.
• Age-related elastin degradation contributes to skin wrinkling and loss of elasticity.
• Elastases and their inhibitors are therapeutic targets in inflammatory and fibrotic diseases.
• Quantitative methods such as QCM and nanoplasmonic sensing enable real-time monitoring of elastin proteolysis.
• CRISPR screens can identify novel regulators of elastin catabolic process.
• Elastin catabolism is relevant to tissue engineering and biomaterial design.
• Understanding elastin degradation aids in diagnosing connective tissue disorders.
• Modeling elastin catabolism in vitro supports drug discovery for anti-aging and antifibrotic therapies.
What Happens During elastin catabolic process?
Initiation by Elastases
In simple terms: Elastin breakdown starts when enzymes called elastases cut the elastin protein.
Elastin catabolic process is initiated by elastases, a group of proteases that include neutrophil elastase, macrophage elastase (MMP-12), and other matrix metalloproteinases (MMPs). These enzymes recognize and cleave the hydrophobic, crosslinked regions of elastin, leading to the release of soluble peptides. The activity of these proteases is normally controlled by endogenous inhibitors such as alpha-1 antitrypsin and tissue inhibitors of metalloproteinases (TIMPs).
Proteolytic Cleavage and Peptide Release
In simple terms: Once elastases cut elastin, small elastin fragments are released into the surrounding tissue.
Proteolytic cleavage of elastin generates elastin-derived peptides (EDPs) that can have biological activities, including chemotaxis and modulation of cell proliferation. The breakdown is processive, with multiple cleavages required to fully degrade the crosslinked elastin network. Real-time monitoring of this process has been achieved using quartz crystal microbalance and nanoplasmonic sensing, which detect mass changes and refractive index shifts during proteolysis.
ECM Remodeling and Mechanical Consequences
In simple terms: When elastin is degraded, the tissue loses its elastic recoil and becomes stiffer.
Elastin catabolism leads to the loss of elastic fibers, resulting in decreased tissue elasticity and altered mechanical properties. This triggers compensatory ECM remodeling, including increased collagen deposition, which can lead to fibrosis. In blood vessels, elastin degradation contributes to arterial stiffening and aneurysm formation.
Cellular Responses to Elastin Degradation
In simple terms: Cells respond to elastin fragments by changing their behavior, which can drive inflammation or repair.
Elastin-derived peptides can act through receptors such as the elastin receptor complex (ERC) to activate signaling pathways that promote inflammation, angiogenesis, or fibrosis. Macrophages and neutrophils are recruited to sites of elastin degradation, where they release additional proteases, creating a feedback loop. These cellular responses link elastin catabolism to chronic inflammatory diseases.
Regulation by Inhibitors and Cytokines
In simple terms: The breakdown of elastin is kept in check by inhibitor proteins and signals from the immune system.
Endogenous inhibitors such as alpha-1 antitrypsin and TIMPs regulate elastase activity, and an imbalance between proteases and inhibitors leads to excessive elastin degradation. Pro-inflammatory cytokines, including TNF-alpha and IL-1beta, can upregulate elastase expression, further promoting catabolism. This regulation is critical for maintaining tissue homeostasis.
Key Genes Involved in GO:0060309 elastin catabolic process
The following genes and proteins are central to the elastin catabolic process, based on published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| ELN | Encodes elastin, the substrate for degradation | Mutations cause supravalvular aortic stenosis; key for substrate availability |
| ELANE | Neutrophil elastase, a major elastin-degrading enzyme | Target in emphysema and inflammatory diseases |
| MMP12 | Macrophage metalloelastase, degrades elastin | Implicated in COPD and aneurysm |
| MMP2 | Gelatinase A, can degrade elastin | Role in vascular remodeling and cancer |
| MMP9 | Gelatinase B, degrades elastin | Associated with inflammation and fibrosis |
| MMP7 | Matrilysin, elastin-degrading activity | Involved in tissue repair and cancer |
| CTSK | Cathepsin K, elastolytic cysteine protease | Important in bone and vascular biology |
| CTSL | Cathepsin L, can degrade elastin | Role in cancer invasion |
| CTSS | Cathepsin S, elastin-degrading activity | Linked to atherosclerosis |
| SERPINA1 | Alpha-1 antitrypsin, inhibits neutrophil elastase | Deficiency causes emphysema |
| TIMP1 | Inhibits MMPs, including elastases | Regulates ECM turnover |
| TIMP2 | Inhibits MMPs | Modulates elastin degradation |
| TIMP3 | Inhibits MMPs | Protects against elastin breakdown |
| TIMP4 | Inhibits MMPs | Expressed in heart and ECM |
| IL6 | Cytokine that can induce MMPs | Inflammatory regulator of elastin catabolism |
| TNF | Cytokine that upregulates elastases | Promotes elastin degradation in inflammation |
| IL1B | Cytokine that induces MMPs | Drives elastin catabolism in disease |
How Is elastin catabolic process Regulated?
Elastin catabolic process is regulated at multiple levels. Transcriptional regulation of elastase and MMP genes by inflammatory cytokines such as TNF and IL-1beta increases their expression. Post-translational activation of pro-MMPs by proteases and reactive oxygen species also promotes elastin degradation. Endogenous inhibitors, including alpha-1 antitrypsin and TIMPs, provide a counterbalance, and their deficiency or inactivation leads to excessive elastin breakdown. Hormonal and growth factor signaling, such as TGF-beta, can modulate ECM turnover and elastin catabolism. Additionally, mechanical stretch and aging-related changes in ECM stiffness can influence protease activity.
elastin catabolic process and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| ELANE | Emphysema, inflammation | Knockout mice or cell lines to assess elastin degradation |
| MMP12 | COPD, aneurysm | Overexpression and knockout models in macrophages |
| SERPINA1 | Alpha-1 antitrypsin deficiency | Point mutation knock-in to mimic deficiency |
| ELN | Supravalvular aortic stenosis, cutis laxa | Knock-in of patient mutations in iPSCs |
| MMP9 | Fibrosis, cancer | CRISPR knockout in fibroblasts |
Pulmonary Fibroelastosis and Emphysema
Pulmonary fibroelastosis is characterized by excessive elastin deposition and degradation, leading to stiff lungs and impaired gas exchange. In emphysema, an imbalance between elastases and alpha-1 antitrypsin causes progressive elastin degradation, resulting in alveolar destruction. These conditions highlight the importance of elastin catabolic process in respiratory diseases.
Vascular Remodeling and Aneurysms
Elastin degradation in arterial walls contributes to aortic aneurysms and arterial stiffness. Increased activity of MMPs and cysteine cathepsins degrades elastin, weakening the vessel wall and promoting dilation. Targeting elastin catabolism is a potential therapeutic strategy for vascular diseases.
Skin Aging and Connective Tissue Disorders
Age-related elastin degradation leads to loss of skin elasticity and wrinkle formation. In connective tissue disorders such as cutis laxa, mutations in elastin or elastin-associated genes cause defective elastic fibers that are prone to degradation. Understanding elastin catabolic process aids in developing anti-aging and therapeutic interventions.
From elastin catabolic process-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does gene X regulate elastin degradation? | CRISPR knockout in primary fibroblasts or macrophages |
| Does a specific point mutation alter elastase activity? | Point-mutation knock-in in cell lines |
| Can a tagged elastase be tracked in live cells? | Knock-in of fluorescent tag at endogenous locus |
| Does overexpression of MMP12 increase elastin breakdown? | Overexpression cell model |
| What is the effect of SERPINA1 deficiency on elastin? | Knockout or point mutation in hepatocytes |
| Can CRISPR screen identify novel elastin regulators? | Genome-wide CRISPR library screening |
How to Study the elastin catabolic process Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Quartz crystal microbalance | Mass changes during elastin proteolysis | Real-time monitoring of elastase activity |
| Nanoplasmonic sensing | Refractive index shifts | Label-free detection of elastin degradation |
| Atomic force microscopy | Surface morphology and stiffness | Validation of elastin fiber degradation |
| Immunostaining | Elastin fiber integrity | Tissue and cell imaging |
| RNA-seq | Gene expression changes | Identifying regulators of elastin catabolism |
| Proteomics | Protein abundance and modifications | Discovering elastin-degrading enzymes |
| CRISPR screening | Gene function on a genome-wide scale | Finding novel elastin catabolism regulators |
| ELISA | Elastin-derived peptide levels | Quantifying elastin breakdown in samples |
Proteolysis Assays
Elastin catabolic process can be measured using in vitro proteolysis assays with insoluble elastin or synthetic substrates. Real-time monitoring with quartz crystal microbalance and nanoplasmonic sensing allows label-free detection of elastin degradation. These methods quantify the rate of elastin breakdown and can be used to screen inhibitors.
Imaging and Morphological Validation
Atomic force microscopy (AFM) provides morphological validation of elastin degradation at the nanoscale. Immunostaining for elastin and confocal microscopy can visualize elastic fiber integrity in tissues and cell cultures. These imaging techniques complement biochemical assays.
Genomic and Proteomic Approaches
RNA-seq and proteomics can identify changes in elastase and MMP expression during elastin catabolism. CRISPR screens coupled with next-generation sequencing enable discovery of novel regulators. Bioinformatics analysis of ECM-related gene signatures can reveal pathways linked to GO:0060309.
Cell-Based Models
Primary fibroblasts, smooth muscle cells, and macrophages are commonly used to study elastin degradation. These cells can be stimulated with cytokines to induce elastases, and elastin breakdown can be quantified by ELISA for elastin-derived peptides. Co-culture systems mimic tissue complexity.
How CRISPR Can Be Used to Study GO:0060309 elastin catabolic process
Knockout
CRISPR knockout of elastase or MMP genes (e.g., ELANE, MMP12) in cell models can abolish elastin degradation, providing causal evidence for their role in GO:0060309. Knockout of inhibitor genes such as SERPINA1 can increase elastin breakdown, mimicking disease states.
Point Mutation
Point mutations in ELN or SERPINA1 that are associated with disease can be introduced using CRISPR base editing or homology-directed repair to study their impact on elastin catabolism. These models help dissect the functional consequences of specific variants.
Knock-in
Knock-in of fluorescent tags (e.g., GFP) at the endogenous ELANE or MMP12 locus allows real-time tracking of elastase secretion and localization during elastin degradation. Knock-in of patient mutations in ELN can model connective tissue disorders.
Overexpression
CRISPR activation (CRISPRa) or lentiviral overexpression of elastases (e.g., MMP12) can drive excessive elastin degradation, modeling emphysema or aneurysm. Overexpression of TIMPs can protect against elastin breakdown, validating their regulatory role.
How EDITGENE Supports elastin catabolic process Research
Researchers studying elastin catabolic process-related genes often need to determine whether a candidate gene is causally involved in elastin degradation, how specific mutations alter protease activity, or whether a gene product can be tracked in live cells. EDITGENE provides tailored CRISPR cell models and screening services to address these questions with rigor and reproducibility.
Contact EDITGENE today to design your custom CRISPR model for elastin catabolic process research.
Frequently Asked Questions About elastin catabolic process
What is GO:0060309 elastin catabolic process?
GO:0060309 is a Gene Ontology biological process term defined as the chemical reactions and pathways resulting in the breakdown of elastin, a crosslinked glycoprotein in connective tissue.
What genes are involved in elastin catabolic process?
Key genes include ELN (elastin), ELANE (neutrophil elastase), MMP2, MMP9, MMP12, CTSK, and inhibitors such as SERPINA1 and TIMPs.
Which enzymes degrade elastin?
Elastases, including neutrophil elastase, macrophage metalloelastase (MMP-12), and cysteine cathepsins, degrade elastin.
How is elastin catabolic process regulated?
It is regulated by a balance between elastases and inhibitors (e.g., alpha-1 antitrypsin, TIMPs), and by inflammatory cytokines such as TNF and IL-1beta.
What diseases are associated with elastin degradation?
Pulmonary fibroelastosis, emphysema, aortic aneurysms, and skin aging are linked to dysregulated elastin catabolism.
How can I study elastin catabolic process in the lab?
Methods include proteolysis assays, quartz crystal microbalance, nanoplasmonic sensing, atomic force microscopy, RNA-seq, and CRISPR screens.
What CRISPR models are available for elastin catabolism research?
Knockout, point mutation, knock-in, and overexpression models can be generated for elastase, MMP, and inhibitor genes.
Can elastin degradation be measured in real time?
Yes, label-free techniques such as quartz crystal microbalance and nanoplasmonic sensing allow real-time monitoring of elastin proteolysis.
What is the role of elastin-derived peptides?
Elastin-derived peptides can act as signaling molecules that influence inflammation, cell proliferation, and fibrosis.
Why is elastin catabolic process important for aging?
Age-related elastin degradation leads to loss of skin elasticity and arterial stiffening, contributing to aging phenotypes.
Conclusion
Elastin catabolic process (GO:0060309) is a fundamental biological process that governs the breakdown of elastin, a key structural protein in connective tissues. Its dysregulation is implicated in a range of diseases, from pulmonary fibroelastosis to vascular aneurysms and skin aging. Advances in real-time monitoring and CRISPR-based models are accelerating our understanding of the enzymes, inhibitors, and cellular responses involved. Targeting elastin catabolism holds promise for therapeutic intervention in fibrotic and age-related conditions.
References
- 1. Wise SG et al.. 2009. Tropoelastin.. Int J Biochem Cell Biol 41(3):494-7 PMID: 18468477
- 2. Labat-Robert J et al.. 1990. Extracellular matrix.. FEBS Lett 268(2):386-93 PMID: 2166694
- 3. Yombo DJK et al.. 2023. Pulmonary fibroelastosis - A review.. Matrix Biol 124:1-7 PMID: 37922998
- 4. Szczepanczyk M et al.. 2026. Label-free and real-time synchronized monitoring of extracellular matrix proteolysis using quartz crystal microbalance and nanoplasmonic sensing with morphological validation by atomic force microscopy.. J Colloid Interface Sci 703(Pt 1):139139 PMID: 41056850
- 5. Birch HL. 2018. Extracellular Matrix and Ageing.. Subcell Biochem 90:169-190 PMID: 30779010
- 7. Mecham RP. 1991. Laminin receptors.. Annu Rev Cell Biol 7:71-91 PMID: 1667086
- 8. Rungruang R et al.. 2025. Anti-aging potential of Monascus purpureus pigments in skin care.. Pharm Biol 63(1):683-697 PMID: 40964924
